Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: A radio-genomic study.
Hematol Oncol
; 40(4): 645-657, 2022 Oct.
Article
in En
| MEDLINE
| ID: mdl-35606338
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hodgkin Disease
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Hematol Oncol
Year:
2022
Document type:
Article
Affiliation country:
Italy
Country of publication:
United kingdom